ESC and ERS Cowrite New Pulmonary Hypertension Guidelines with Novel Treatment Algorithms

The European Society of Cardiology (ESC) together with the European Respiratory Society (ERS) recently launched a new treatment algorithm for pulmonary arterial hypertension in its updated pulmonary hypertension guidelines. The amended protocol aims to provide patients with the best chance of a positive clinical outcome despite being diagnosed with an untreatable, highly debilitating, and limiting disease.

 

The new guidelines are now published online in the European Heart Journal, European Respiratory Journal as well as on the ESC Website. The two societies co-wrote the document, which also draws from evidence collated by the previous set of guidelines from 2009.

The document introduces the new treatment algorithm for pulmonary arterial hypertension (PAH) together with treatment tables summarizing when to administer some of today’s newer medications. Outlined treatment strategies take patients’ risk profiles into account, and sequential and initial combination therapies are recommended based on new findings, and for the first time, early consideration for lung transplantation is recommended. A new treatment algorithm for chronic thromboembolic pulmonary hypertension (CTEPH) has also been made available, and includes surgical, medical and interventional strategies.

Professor Nazzareno Galiè, ESC Chairperson of the guidelines Task Force, said: “Since the 2009 guidelines a huge amount of evidence has accumulated on the pharmacological treatment of patients with PAH. We have reconciled all the available data in a comprehensive treatment algorithm and in multiple tables that give recommendations for different patient risk profiles. The information is inclusive enough to be applicable in different healthcare systems with heterogeneous drug availability. The algorithm for CTEPH is more detailed and recommends specific imaging tests to better define the treatment strategy.”

Both clinical and hemodynamic classifications have been updated with newer evidence on genetic and drug causes. Disorders among children have been classified, and pulmonary vascular resistance (PVR) has been included in the diagnosis of PAH. The document also introduces a novel diagnostic algorithm that starts with the echocardiographic probability of pulmonary hypertension (low, intermediate, high) and is followed by identification of the most common causes such as pulmonary hypertension due to heart diseases, lung diseases and CTEPH.

RELATED: Highlights on New Theory for Pulmonary Arterial Hypertension: The Metabolic Theory

“Pulmonary hypertension can involve multiple clinical conditions,” said Professor Marc Humbert, European Respiratory Society (ERS) Co-Chairperson of the guidelines Task Force. “The updated classifications and new diagnostic algorithm will help clinicians to better define an individual patient’s disease so that the most appropriate treatment can be given.”

Expert centers are given a pivotal role in the management of pulmonary hypertension, starting with the diagnostic process. Professor Humbert said: “Right heart catheterization is recommended for confirming the final diagnosis of PAH and CTEPH and this technically demanding procedure provides more accurate information and has lower morbidity when performed in expert centres. Patients with established hypertension should be referred early to expert centres to ensure they are given the best care.”

The new guidelines marks the first time satisfactory/unsatisfactory clinical responses to treatment are defined based on the change or maintenance of an individual patient’s risk profile. There are 9 clinical, functional, exercise, biochemical, imaging and haemodynamic parameters to be assessed in order to arrive at an estimated one year mortality of (<5%), intermediate (5-10%), or high (>10%).

Professor Galiè concluded: “The new data and the new recommendations included in this updated version of the pulmonary hypertension guidelines are intended to provide a practical approach to the management of these complex patients. In addition, the typical multidisciplinary approach will enhance the level of collaboration between various specialists and centres with different levels of expertise and experience.”

Comment

  • Donna Donna Tuesday, 01 September 2015

    I was more than happy to uncover this web site. I want
    to to thank you for your time for this wonderful read!!

    I definitely really liked every bit of it and I have
    you saved to fav to check out new things in your website.

  • Mohamed Mohamed Tuesday, 01 September 2015

    Great website you have here but I was wanting to know if you knew
    of any forums that cover the same topicfs discussed here?

    I'd really like to be a part of group where I can get suggestions from other experienced individuals that share the same interest.
    If you have any suggestions, please let me know.
    Kudos!

  • Lovie Lovie Tuesday, 01 September 2015

    If some one wants to be updated with most recent technologies therefore he must be pay a quick visit this website and be up to date every day.

  • Kathlene Kathlene Tuesday, 01 September 2015

    Woah! I'm really lopving the template/theme of this site.
    It's simple, yet effective. A lot of times it's challenging to get that "perfect balance"
    between user friendliness and visual appearance. I must say you've done a excellent job with this.
    Also, the blog loads very quick for me on Safari. Superb Blog!

  • Junko Junko Tuesday, 01 September 2015

    In the course of training, take the time to review the essentials and relearn the best way to do them perfectly.
    You might find others especially soccer insiders making recommendations back to place
    your wager to those typical teams that are generally
    not considered as favorites inside overall tournament as their
    likelihood is always at constant or improving. Sbobet is a
    large enterprise which is currently engaged in betting soccer betting.

  • Aretha Aretha Tuesday, 01 September 2015

    This excellent website truly has all the information and facts I needed about this subject and didn't know who to ask.

  • Dillon Dillon Tuesday, 01 September 2015

    Hello there! This article couldn't be written much better!
    Reading through this article reminds me off my previous roommate!
    He continually kept talking about this. I'll send this article to him.
    Fairly certain he'll have a good read. Thanks for sharing!

  • Dorris Dorris Tuesday, 01 September 2015

    Please let me know if you're looking for a author for your blog.
    You have some really great articles and I think I would
    be a good asset. If you ever want to take some
    of the load off, I'd really like to write some material for your blog in exchange for a link back to mine.
    Please shoot me an e-mail if interested. Many thanks!

  • Etsuko Etsuko Tuesday, 01 September 2015

    Can I just say what a comfort to uncover an individual who really understands what they are discussing over the internet.
    You definitely know how to bring a problem to light and
    make it important. A lot more people should read
    this and understand this side of your story. It's surprising you
    aren't more popular given that you surely possess the gift.

  • Genia Genia Tuesday, 01 September 2015

    We stumbled over here coming from a different web page and
    thought I should check things out. I like
    what I see so now i'm following you. Look forward to exploring your web page yet again.

Leave your comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

About Us

The Saudi Association for Pulmonary Hypertension (SAPH) is a medical and research national group of many medical specialists, who shared a common interest in the field of pulmonary vascular disease. The main goal for SAPH is to increase the awareness and the knowledge of pulmonary vascular diseases in the society and between the medical professionals.

The Saudi Association for Pulmonary Hypertension (SAPH) is a Subsidiary of The

Saudi Association for PH

STS office (Exit 11 & the Airport Road)

Riyadh, Saudi Arabia

P. O. Box 106911
Riyadh 11676
Saudi Arabia

Tel:+966-11-2488966
Fax: +966-11-2487431
Mobile:+966506426704

We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…